CannaList Conversations with Lars Moehring of Cannify

CannaList Conversations had the chance to sit down with Lars Moehring of Cannify, a pharmaceutical wholesaler, since 2018.

Discover the regulatory world of Medicinal Cannabis in Germany with the Founder of Cannify.  A must-watch for those wondering about the challenges of growing a medical cannabis brand in Germany.

Lars is the Co-Founder and current CEO of Cannify Pharma GmbH. His company was established in 2018 and is now operating as a fully licensed Importer and Distributor of medical cannabis in the german market. Cannify thrives on contributing to people’s well-being by developing and distributing high-quality EU-GMP-certified medical cannabis products.

Cannify Pharma GmbH is a fully licensed wholesaler for the direct sale of medicinal cannabis to pharmacies. It supplies pharmacies with selected, high-quality products to guarantee patients the best possible therapeutic success.

All of its products are EU-GMP certified.

All of its partners within the value chain are subject to strict controls, which enable it to offer a high-quality range of medical cannabis products.

CannaList Conversations is brought to you by CannaList.

To compete in today’s markets effectively, growing businesses need access to the same breadth and depth of services traditionally accessible only to more significant business organizations. As a result, we allow growing companies to complete critical business functions.

CannaList Conversations with Lars Moehring of Cannify